Anacor Pharmaceuticals to Present at the 2011 Wedbush Life Sciences Conference - MarketWatch (press release)

Anacor Pharmaceuticals to Present at the 2011 Wedbush Life Sciences Conference MarketWatch (press release) In addition, Anacor is nonindustrial AN2718 as a topical antifungal product candidate for the treatment of onychomycosis and skin fungal infections, and AN2898 as type A topical anti-inflammatory product nominee for the treatment of psoriasis and atopic ... and more » Link To Article